Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A
出版年份 2014 全文链接
标题
Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A
作者
关键词
-
出版物
Cell Death & Disease
Volume 5, Issue 7, Pages e1359-e1359
出版商
Springer Nature
发表日期
2014-07-31
DOI
10.1038/cddis.2014.325
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
- (2013) Parthasarathy Seshacharyulu et al. CANCER LETTERS
- Multiple interactive factors in hepatocarcinogenesis
- (2013) Jin Ding et al. CANCER LETTERS
- Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target
- (2013) A. Khanna et al. CANCER RESEARCH
- Regulation of the MicroRNA 200b (miRNA-200b) by Transcriptional Regulators PEA3 and ELK-1 Protein Affects Expression of Pin1 Protein to Control Anoikis
- (2013) Xusen Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation
- (2013) Nian-Kang Sun et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Decreased Tumor Progression and Invasion by a Novel Anti-Cell Motility Target for Human Colorectal Carcinoma Cells
- (2013) Qunyan Jin et al. PLoS One
- Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma
- (2012) Hui-Chuan Yu et al. BIOCHEMICAL PHARMACOLOGY
- Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissues
- (2012) Pinzhu Huang et al. BIOMARKERS
- Immunohistochemical study of pElk-1 expression in human breast cancer: Association with breast cancer biologic profile and clinicopathologic features
- (2012) Aggelos Laliotis et al. BREAST
- CIP2A Is Highly Expressed in Hepatocellular Carcinoma and Predicts Poor Prognosis
- (2012) Hui He et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells
- (2012) C.-Y. Liu et al. HAEMATOLOGICA
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
- (2012) Nadzeya Goncharenko-Khaider et al. Molecular Cancer
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy
- (2011) C H Switzer et al. ONCOGENE
- Overexpression and Small Molecule-Triggered Downregulation of CIP2A in Lung Cancer
- (2011) Liang Ma et al. PLoS One
- Epidermal growth factor regulates PAI-1 expression via activation of the transcription factor Elk-1
- (2010) Paulina Wyrzykowska et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells
- (2010) K-F Chen et al. ONCOGENE
- Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency
- (2009) Hsiang-Yuan Yeh et al. BMC Medical Genomics
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
- (2009) Sean F. Altekruse et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis
- (2008) Hye Jung Baek et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple pathways regulated by the tumor suppressor PP2A in transformation
- (2008) Jukka Westermarck et al. TRENDS IN MOLECULAR MEDICINE
- Antisense oligonucleotide Elk-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells
- (2007) T YING et al. CELL BIOLOGY INTERNATIONAL
- Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival
- (2007) Melissa R. Junttila et al. FASEB JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started